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INTRODUCTION
Reactive lymphoid hyperplasia (RLH), known as pseudolym-
phoma, is a rare condition that has been observed in the liver.
It is characterized by a marked proliferation of polyclonal and
non-neoplastic lymphoid cells with the formation of abundant
follicles that have active germinal centers (1, 2). It is usually
localized and well demarcated from the surrounding tissue.
RLH is thought to represent an immune-mediated reactive
phenomenon, and may arise in association with a malignant
tumor (2, 3). We report a case of RLH of the liver that mim-
icked a metastatic carcinoma, based on radiological findings
in a patient with renal cell carcinoma. In particular, the his-
tiocyte-rich RLH pattern observed in this case, which seems
to be an uncommon feature of RLH, is discussed.
CASE REPORT
A 46-yr-old woman underwent a radical right nephrectomy
for stage I renal cell carcinoma of the clear cell type. A follow-
up computed tomography (CT) scan was done 14 months later
and revealed a new mass in segment 5 of the liver. It was 1.0
cm in diameter and well-defined round-shaped mass showing
high attenuation at arterial phase imaging and slight low atten-
uation at portal and equilibrium phase imaging. For further
evaluation of this mass, a magnetic resonance (MR) examina-
tion was performed. On T2-weighted MR imaging, this mass
showed an intermediate hyperintensity-like liver malignancy
(Fig. 1A). On gadolinium-enhanced MR imaging, this mass
showed bright nodular enhancement at arterial phase imag-
ing (Fig. 1B) and peripheral rim-like enhancement at delayed
phase imaging, which was interpreted as a metastatic renal
cell carcinoma or hypervascular hepatocellular carcinoma. A
physical examination and chest roentgenogram were unremark-
able. Laboratory data were all within the normal range and the
results of liver function tests were normal (aspartate aminotrans-
ferase [AST] 21 U/L, alanine aminotransferase [ALT] 33 U/L,
total bilirubin 0.66 mg/dL, alkaline phosphatase 94 U/L, and
lactate dehydrogenase [LDH]154 U/L). A test for the hepatitis
B antibody was positive. The level of carcinoembryonic anti-
gen was 3.7 ng/mL (normal -5), and CA19-9 was slightly ele-
vated (41.98 U/mL, normal -36). Alpha-fetoprotein levels and
anti-mitochondrial antibodies were not available. A diagno-
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Histiocyte-Rich Reactive Lymphoid Hyperplasia of the Liver:
Unusual Morphologic Features
Reactive lymphoid hyperplasia (RLH) of the liver is a rare entity and has also been
termed nodular lymphoid lesion or pseudolymphoma of the liver. We report a case
of hepatic RLH exhibiting unusual histiocyte-rich histologic features in a 47-yr-old
woman in conjunction with a renal cell carcinoma. A follow-up computed tomog-
raphy scan was done 14 months after a right radical nephrectomy for renal cell car-
cinoma revealed a nodular lesion in segment 5 of the liver. The lesion was interpret-
ed as metastatic renal cell carcinoma or hepatocellular carcinoma based on the
history of the patient and radiologic findings. Wedge resection of segment 5 was
done with sufficient distance from the mass. Microscopically, the lesion was com-
posed predominantly of peculiar histiocytic proliferation and was characterized by
lymphoid aggregates forming a lymphoid follicle with germinal centers. The present
case and prior cases reported in the literature suggest that RLH of the liver appear
to be a heterogenous group of reactive inflammatory lesions that are often associ-
ated with autoimmune disease or malignant tumors.
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sis of metastatic renal cell carcinoma from the previous renal
cell carcinoma was presumed, based on the prior history of
the patient and radiological findings, and wedge resection of
segment 5 including the mass was performed ensuring ade-
quate distance from the mass. Grossly, the resected liver seg-
ment contained a well-circumscribed, yellowish-white, soli-
Fig. 1. (A) The respiratory-triggered T2-weighted turbo spin-echo MR imaging shows a small mass with intermediate high signal intensity
(arrow) in liver segment 5. (B) The gadolinium-enhanced arterial phase MR imaging shows small bright nodular enhancement (arrow) in the
same location as in A.
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Fig. 2. (A) A cut section of the resected liver shows a well-circumscribed, yellowish-white mass in segment 5. (B) The lesion is composed
predominantly of peculiar histiocytic proliferation and lymphoid aggregate forming lymphoid follicles on the edge of the nodule. Note the dense
infiltrate of lymphocytes in several portal tracts immediately around the nodule (arrows, ×20, H&E). (C, D) The lesion is mainly composed
of aggregates of epithelioid histiocytes simulating non-caseating granuloma (C ×200, D ×400, H&E). (E) Hyalinized structures in the nod-
ule (arrow, ×200, H&E). (F) CD68 immunostaining highlights the large number of histiocytes (×200, CD68).
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tary nodule of firm consistency, measuring 1 cm in diameter
(Fig. 2A). Microscopically, the lesion was composed predom-
inantly of a peculiar histiocytic proliferation without signif-
icant atypia and was characterized by lymphoid aggregates
forming a lymphoid follicle with germinal centers (Fig. 2B,
C). Most of the follicles were observed on the edge of the nod-
ule. There was also marked hyalinization in part of the mass,
and several bile ductules were observed on the edge of the
nodule. In the surrounding liver tissue, a marked periduc-
tular fibrosis with prominent lymphocytic infiltration was
also observed (Fig. 2B). However, the hepatic parenchyma
distant from this nodule was normal and lymphoid infiltra-
tion was not detected in the portal tracts. The bile duct sys-
tem contained no stones. Lymphoid cells positive for L-26
(B cell marker, DAKO, Glostrup, Denmark) were distribut-
ed mainly in the germinal centers, while those positive for
UCHL-1 (T cell marker, DAKO) were present around the
germinal centers. There were no cytokeratin-positive malig-
nant epithelial cells in the nodule. CD68 (histiocyte mark-
er, DAKO) immunostaining highlighted the large number
of histiocytes with epithelioid cell features (Fig. 2D). HMB45
(marker for angiomyolipoma, DAKO)-positive cells were not
detected. Use of special stains, such as periodic acid-Schiff,
Grocott, and Ziehl-Neelsen stains failed to demonstrate any
microorganisms in the lesion. A polymerase chain reaction
analysis for mycobacteria was negative.
DISCUSSION
In the liver, RLH has also been variously termed as nodular
lymphoid lesion (2, 4) and pseudolymphoma (5-9). A review
of the literature has revealed that 17 cases of RLH of the liver
have been reported to date (Table 1). Including the present
case, the age of patients ranged from 36 to 85 yr (average,
60.5 yr). There was a female predilection with a female-to-male
ratio of 8:1. In terms of underlying disease, chronic hepati-
tis (6, 8), autoimmune disease such as Sjogrens disease (9),
chronic thyroiditis (10), primary biliary cirrhosis (2), CREST
syndrome (2), and diabetes mellitus (1, 7) have been report-
ed. Hence, autoimmune mechanisms seem to be most like-
ly involved in the RLH occurrence.
By definition, the diagnosis of RLH is based on a polymor-
phous lymphocytic infiltration, and often numerous germinal
centers, without cytologic atypia; however, on the basis of the
published pathologic descriptions, this seemed to be variable
both in extent and in cellular composition. In nine cases, lym-
phoid infiltration was seen in the portal areas around the nod-
ule. However, including the current case, lymphoid infiltra-
tion was confined to the portal tracts immediately around the
nodule; the rest of the hepatic parenchyma was normal, sug-
gesting that this lesion was local rather than diffuse (1-3, 7,
10-13). We can speculate that several lymphoid follicles in
these portal areas conglomerated and formed an RLH lesion.
Few lymphoepithelial lesions were present (2, 4), and in one
case Ig-light chain restriction has been observed by immuno-
histochemistry (2). However, there was no evidence of a mon-
oclonal B cell population by molecular genetic analysis (2, 13).
Tanizawa and colleagues reported a RLH of the liver charac-
terized by an angiofollicular pattern with interfollicular hyalin-
ization mimicking Castlemans desease (14). In five cases includ-
ing the case reported here, hyalinized trabecular structures in
the nodule were present (2, 11, 13, 14). The peculiar histio-
cytic proliferation in the present case consisted of a granulo-
matous arrangement of epithelioid histiocytes, which is sim-
ilar to the characteristic features of a non-caseating granuloma.
However, periodic acid-Schiff, Grocott, and Ziehl-Neelsen
stains failed to demonstrate any microorganisms in the lesion.
Furthermore, the histologic findings of lymphoid follicles with
active germinal centers in our case are not seen in other gran-
ulomatous lesions, such as sarcoidosis. Among the RLH of the
liver cases we reviewed, only one case exhibited aggregates of
epithelioid histiocytes in the nodule as seen in the case present-
ed here. These findings suggest that RLH of the liver appear
to represent a heterogenous group of reactive inflammatory
lesions that share a varying degree of inflammation, rather than
a specific entity.
Including the present patient, seven cases of hepatic RLH
accompanying malignant tumors have been reported (3, 5, 8,
11, 13): in two each cases of colon cancer (3) and gastric can-
cer (5, 8). One patient with multiple carcinomas (gastric, cecal,
and colon cancer) has presented with hepatic RHL (13). Pan-
tanowitz and colleagues have described an RLH of the liver
in a patient with a renal cell carcinoma (11). Surprisingly, the
histopathologic findings including the presence of lymphoid
follicles with germinal centers, hyalinized trabecular structures,
and lymphocytic infiltration in the portal tracts around the
nodular lesion, are very similar to those seen in the present
case. These findings suggest a possible correlation between
hepatic RLH and renal cell carcinoma. However, there have
been very few cases, so it is not clear whether the renal cell
carcinoma was involved in the onset of the hepatic RLH. We
can speculate that the etiology of RLH of the liver may be
related to an immunologic abnormality that is caused by the
malignant tumor itself or previous surgery for the tumors. The
prognosis of the RLH associated with malignancies is good,
and most patients treated by resection of this lesion have shown
no recurrence or progression to lymphoma (3, 11).
Although our case showed some features of an inflammatory
pseudotumor, it has other histologic findings that are not seen
in an inflammatory pseudotumor, including the absence of
fibroblastic proliferation, a lack of prominent fibrosis, collec-
tion of foamy histiocytes, or occlusive endophlebitis. Further-
more, the histologic features of inflammatory pseudotumors
do not necessarily contain lymphoid follicles that are always
found in RLH (7). Thus, our lesion is histologically different
from an inflammatory pseudotumor.
Radiologically, RLH should be differentiated from other
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solid focal hepatic lesions as both conditions show interme-
diate hyper-intensity on T2-weighted MR imaging. In par-
ticular, the RLH in our case showed bright nodular enhance-
ment on arterial phase MR imaging, which may be misinter-
preted as hypervascular metastasis from a renal cell carcinoma
or a hypervascular hepatocelluar carcinoma. The imaging find-
ings of our case might be similar to those of previous reports
demonstrating variable enhancement of RLH using contrast-
enhanced CT, CT during angiography, and direct hepatic an-
giography (3, 6, 8, 10, 12). However, since the imaging modali-
ties used in published reports were variable, a further evalu-
ation with a large number of cases will be required in order
to define clearly the radiological findings of this entity.
Rt., right; Lt., left; Seg, segment.
Special histologic features in addition to lymphoid Cases (reference) Age/Sex Size (cm) 
follicles with germinal center
Associated disease
location
Grouls (5) 85/F 1.4×0.8 Gastric cancer
0.8×0.7
Rt. lobe
Isobe et al. (1) 59/F 0.9 Lymphocytic infiltration in the portal tracts around the Diabete mellitus
Lt. lobe nodular lesion
Ohtsu et al. (6) 42/F 1.5×1.3 Chronic hepatitis B
Seg 6
Katayanagi et al. (7) 66/F 1.5×1.0 Lymphocytic infiltration in the portal tracts around the  Diabete mellitus
Rt. lobe nodular lesion
Tanizawa et al. (14) 67/F 2.0 Angiofollicular structures mimicking Castleman s disease
Lt. lobe Hyalinized interfollicular spaces
Kim et al. (8) 72/M 1.7×1.5 Chronic active hepatitis of the non-tumorous liver Chronic hepatitis C
Seg 3 Gastric cancer
Sharifi et al. (2) 52/F 0.4 Lymphoepithelial lesions Primary biliary cirrhosis
Rt. lobe Strands of amorphous, dense hyalinized materials
Thick-walled arterioles
56/F 1.5 Rare lymphoid follicles CREST syndrome
Lt. lobe Aggregates of epithelioid histiocytes
Lymphocytic infiltration in the portal tracts around the
nodular lesion
56/M 0.7 Lymphoepithelial lesions Chronic diverticular
?  Scattered giant cells and epithelioid histiocytic aggregates disease
Drug-induced hepatitis
Nagano et al. (10) 47/F 1.0 Chronic thyroiditis
Seg 7 Hemangioma of the liver
Pantanowitz et al. (11) 69/F 1.7×1.0 Numerous hyalinized trabeculated structures Renal cell carcinoma
Rt. lobe Lymphocytic infiltration in the portal tracts around the
nodular lesion
Okubo et al. (9) 49/F 2.0 Sjogren s syndrome
Rt. lobe
Takahashi et al. (3) 77/F 1.5 Lymphocytic infiltration in the portal tracts around the  Colon cancer
Seg 3 nodular lesion
64/F 0.9×0.7 Lymphocytic infiltration in the portal tracts around the Colon cancer
Seg 2 nodular lesion
Maehara et al. (12) 72/F 1.3×1.0 Lymphocytic infiltration in the portal tracts around the 
Seg 3 nodular lesion
Willenbrock et al. (4) 36/F 1.8 Epithelioid cells, and giant cells in the interfollicular area Focal nodular hyperplasia 
Seg 8 Lymphoepithelial lesions Hemangioma
Sato et al. (13) 75/F 1.4 Hyalinized fibrous tissues Gastric, cecal, and
Rt. lobe Lymphocytic infiltration in the portal tracts colon cancer
around the nodular lesion
Present case 46/F 1.0×1.0 Florid aggregates of epithelioid histiocytes Renal cell carcinoma
Seg 5 Rare lymphoid follicles
Lymphocytic infiltration in the portal tracts
around the nodular lesion
Hyalinized materials
Table 1. Cases of reactive lymphoid hyperplasia of the liver in the literature and the present case
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